🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kelly Vallance

Cook Children's Medical Center

ORCID: 0000-0003-4185-921X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.292Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101850
Top 56%
0.292DataRank
Top 56%4 citations

Stephanie A. Felker, Surya P. Rednam, Kelly Vallance, D. Williams Parsons, Angshumoy Roy +3 more

Papers

Driven by 10 papers — median percentile 22. Top paper: “Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2”.

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Cancer(2020)10.1002/cncr.32855
N/A
1.0DataRank · unranked
30 citations

Elizabeth A. Mullen, James I. Geller, Yueh‐Yun Chi, Geetika Khanna, Richard D. Glick +7 more

Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors

Med(2022)10.1016/j.medj.2022.09.002
N/A
0.457DataRank · unranked
20 citations

Prabhjot S. Mundi, Lianna J. Marks, Chelsey Burke, Michael V. Ortiz, Daniel Diolaiti +17 more

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101850
Top 56%
0.292DataRank
Top 56%4 citations

Stephanie A. Felker, Surya P. Rednam, Kelly Vallance, D. Williams Parsons, Angshumoy Roy +3 more

BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children’s Oncology Group Study AREN03B2

Archives of Pathology & Laboratory Medicine(2023)10.5858/arpa.2022-0528-oa
N/A
0DataRank · unranked
2 citations

Lindsay A. Renfro, Lawrence J. Jennings, Elizabeth A. Mullen, James I. Geller, Kelly Vallance +3 more

Frequency and spectrum of clinically significant molecular alterations detected by tumor gene panel testing for pediatric cancer patients in the Texas KidsCanSeq study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10018
N/A
0DataRank · unranked
0 citations

Jacquelyn Reuther, Samara L. Potter, Ross Mangum, Carrie Mohila, John Hicks +15 more

Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity

medRxiv(2023)10.1101/2023.10.30.23297632
Top 100%
0DataRank
Top 100%0 citations

Stephanie A. Felker, Surya P. Rednam, Kelly Vallance, D. Williams Parsons, Angshumoy Roy +3 more

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials

Nature Reviews Urology(2025)10.1038/s41585-025-01055-1
N/A
0DataRank · unranked
13 citations

Nicholas G. Cost, Peter F. Ehrlich, Nicholas F. Evageliou, Elizabeth Fialkowski, Lauren Parsons +13 more

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor

Annals of Surgery(2025)10.1097/sla.0000000000006726
N/A
0DataRank · unranked
3 citations

Kelly Vallance, Ian Tfirn, Nicholas F. Evageliou, Daniel J. Benedetti, Robert C. Shamberger +15 more

Children's Oncology Group's 2023 blueprint for research: Renal tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30586
N/A
0DataRank · unranked
29 citations

Andrew L. Hong, Kelly Vallance, Nick Evageliou, Jennifer H. Aldrink, Nicholas G. Cost +4 more

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532

Cancer(2023)10.1002/cncr.35084
N/A
0DataRank · unranked
11 citations

Lindsay A. Renfro, James I. Geller, Elizabeth J. Perlman, John A. Kalapurakal, Arnold C. Paulino +11 more